How effective is Neurontin for Therapeutic Drug Levels? (by duration, gender, age)

Summary:

Overall ratings: 2.3/5
Long term ratings: 3/5

This is a phase IV clinical study of how effective Neurontin (gabapentin) is for Therapeutic drug levels and for what kind of people. The study is created by eHealthMe from 3 Neurontin users and is updated continuously.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Mar, 13, 2023

3 people are studied for taking Neurontin in Therapeutic drug levels


What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 103,941 Neurontin users for its effectiveness, alternative drugs and more.

What is Therapeutic drug levels?

Therapeutic drug levels is found to be associated with 1 drug and 19 conditions by eHealthMe.

Overall effectiveness (number of people):

Does Neurontin work for your Therapeutic drug levels (overall)?

Long term (1+ years) effectiveness (number of people):

Does Neurontin work for your Therapeutic drug levels (long term)?

Neurontin effectiveness for Therapeutic drug levels (number of people):

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 1
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 0
  • very high: 0

Gender of people who take Neurontin for Therapeutic drug levels *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Neurontin for Therapeutic drug levels *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

Who find Neurontin more effective for Therapeutic Drug Levels?

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin?

- You can start a phase IV clinical trial to monitor Neurontin safety and effectiveness.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: